These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15467736)

  • 81. Genomic structure of the human PLZF gene.
    van Schothorst EM; Prins DE; Baysal BE; Beekman M; Licht JD; Waxman S; Zelent A; Cornelisse CJ; van Ommen GJ; Richard CW; Devilee P
    Gene; 1999 Aug; 236(1):21-4. PubMed ID: 10433962
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells.
    Puszyk W; Down T; Grimwade D; Chomienne C; Oakey RJ; Solomon E; Guidez F
    EMBO J; 2013 Jul; 32(13):1941-52. PubMed ID: 23727884
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?
    Licht JD
    J Clin Invest; 2001 Nov; 108(9):1277-8. PubMed ID: 11696570
    [No Abstract]   [Full Text] [Related]  

  • 84. Functions of promyelocytic leukaemia zinc finger (Plzf) in male germline stem cell development and differentiation.
    Clotaire DZJ; Wei Y; Yu X; Ousman T; Hua J
    Reprod Fertil Dev; 2019 Jul; 31(8):1315-1320. PubMed ID: 31009592
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Eating disorder predisposition is associated with ESRRA and HDAC4 mutations.
    Cui H; Moore J; Ashimi SS; Mason BL; Drawbridge JN; Han S; Hing B; Matthews A; McAdams CJ; Darbro BW; Pieper AA; Waller DA; Xing C; Lutter M
    J Clin Invest; 2013 Nov; 123(11):4706-13. PubMed ID: 24216484
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transcriptional repression: lessons from thyroid hormone action and promyelocytic leukaemia.
    Lopez-Liuchi JV; Meier CA
    Eur J Endocrinol; 1998 Sep; 139(3):260-2. PubMed ID: 9758432
    [No Abstract]   [Full Text] [Related]  

  • 87. Plzf pushes stem cells.
    Kotaja N; Sassone-Corsi P
    Nat Genet; 2004 Jun; 36(6):551-3. PubMed ID: 15167928
    [No Abstract]   [Full Text] [Related]  

  • 88. Promyelocytic leukemia zinc finger triggers ATP-binding cassette subfamily E member 1-mediated growth inhibition in breast cancer cells.
    Suliman BA; Al-Yahya S
    Oncol Lett; 2018 Oct; 16(4):4143-4150. PubMed ID: 30214553
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Transcriptional repression in eukaryotes.
    Herschbach BM; Johnson AD
    Annu Rev Cell Biol; 1993; 9():479-509. PubMed ID: 8280469
    [No Abstract]   [Full Text] [Related]  

  • 90. The transcriptional basis of steroid physiology.
    Lin RJ; Kao HY; Ordentlich P; Evans RM
    Cold Spring Harb Symp Quant Biol; 1998; 63():577-85. PubMed ID: 10384323
    [No Abstract]   [Full Text] [Related]  

  • 91. [PLZF-RARĪ± positive acute promyelocytic leukemia: one case report].
    Wen HX; Chen SQ; Wang F; Meng XL; Liu LX; Sun L
    Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):805. PubMed ID: 29081202
    [No Abstract]   [Full Text] [Related]  

  • 92. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation.
    Jia D; Jurkowska RZ; Zhang X; Jeltsch A; Cheng X
    Nature; 2007 Sep; 449(7159):248-51. PubMed ID: 17713477
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.
    Bhat TA; Moon JS; Lee S; Yim D; Singh RP
    Indian J Exp Biol; 2011 Nov; 49(11):848-56. PubMed ID: 22126016
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The biology of HDAC in cancer: the nuclear and epigenetic components.
    Hagelkruys A; Sawicka A; Rennmayr M; Seiser C
    Handb Exp Pharmacol; 2011; 206():13-37. PubMed ID: 21879444
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
    Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
    BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.
    Kim HJ; Bae SC
    Am J Transl Res; 2011 Feb; 3(2):166-79. PubMed ID: 21416059
    [TBL] [Abstract][Full Text] [Related]  

  • 97. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
    Zhang J; Yang Y; Yang T; Liu Y; Li A; Fu S; Wu M; Pan Z; Zhou W
    Br J Cancer; 2010 Oct; 103(8):1215-20. PubMed ID: 20842113
    [TBL] [Abstract][Full Text] [Related]  

  • 98. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
    Noonan EJ; Place RF; Pookot D; Basak S; Whitson JM; Hirata H; Giardina C; Dahiya R
    Oncogene; 2009 Apr; 28(14):1714-24. PubMed ID: 19252524
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1.
    Avvakumov GV; Walker JR; Xue S; Li Y; Duan S; Bronner C; Arrowsmith CH; Dhe-Paganon S
    Nature; 2008 Oct; 455(7214):822-5. PubMed ID: 18772889
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
    Gurel B; Iwata T; Koh CM; Jenkins RB; Lan F; Van Dang C; Hicks JL; Morgan J; Cornish TC; Sutcliffe S; Isaacs WB; Luo J; De Marzo AM
    Mod Pathol; 2008 Sep; 21(9):1156-67. PubMed ID: 18567993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.